The Strategy of Antivirus Treatment in Reproductive Women Infected with Hepatitis B Virus

Chronic hepatitis B is caused by persistent infection with hepatitis B virus (HBY). In the last decade, great progress has been made in the treatment of chronic hepatitis B. Prognosis of chronic hepatitis B has been improved significantly because of the clinical application of nucleoside/nucleotide analogues, such as lamivudine, adefovir dipivoxil, and entecavir. More and more importance of antivirus treatment has been realized. But the physicians are being puzzled by the problems of antivirus treatment in the reproductive women infected with HBY. According to the studies of antiviral drug safety and clinical experiences in treating pregnant women in recent years, we introduce the strategies of antivirus treatment in different periods of reproductive women infected with HBY.